CPHI Online is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Login
View profile
Log out
Welcome back

Click below to sign in and see leads, RFIs or statistics

Sign in

Sign out
- Search Impressions
  
  3 287
- Page views
  
  324
- Request for information
  
  54

Chengdu Shengnuo Biopharm Co Ltd

About Chengdu Shengnuo Biopharm Co Ltd

Chengdu Shengnuo is one of the leading peptide manufacturers in China. There are 5 US-DMF of Peptide APIs: Liraglutide, Bivalirudin, Eptifibatide, Icatibant and Octreotide. The below US-DMFs will be submitted soon: Linaclotide, Degarelix, Teriparatide,Ziconotide,Exenatide and Ganirelix soon. Shengnuo also have a few Chinese GMP APIs: Atosiban,Carbetocin, Octreotide, Enfuvirtide,Thymalfasin, Somatostatin, Thymopentin and Levosimendan.Chengdu Shengnuo Biopharm Co Ltd is a subsidiary of Chengdu Shengnuo Tech Development Co Ltd and was founded in October 2004...

Sales Markets

Africa
Central America (e.g. Mexico)
East Asia (e.g. China, Japan, Korea)
Europe - EU countries
Europe - non EU (e.g. UK, Russia, ex-CIS countries)
Middle East Region (e.g. UAE)
North America (USA, Canada)
Oceania
South America (e.g. Brazil, Colombia)
South Asia (e.g. India, Pakistan, Sri Lanka)
South East Asia (e.g. Thailand, Philippines, Singapore)

Categories

Chengdu Shengnuo Biopharm Co Ltd

CN
2015

On CPHI since

Compare

Add to favorites Added to favorites

Contact info

28-88202608
Website
Section 1, Gongye Avenue, Dayi County, 611330, Chengdu, Sichuan, China

Meet us at

CPHI Japan 2024

East Halls 4, 5 & 6, Tokyo Big Sight, Tokyo, Japan

17 Apr 2024 – 19 Apr 2024

View Exhibitor Profile

CPHI & PMEC China 2024

Shanghai New International Expo Center

19 - 21 June 2024

View Exhibitor Profile

CPHI Korea 2024

COEX, Seoul, Korea

27 - 29 August 2024

View Exhibitor Profile

CPHI Milan 2024

Fiera Milano, Italy

08 Oct 2024 - 10 Oct 2024

View Exhibitor Profile

Products from Chengdu Shengnuo Biopharm Co Ltd (4)

Product Bivalirudin

Use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty .Bivalirudin is a synthetic 20 residue peptide (thrombin inhibitor) which reversibly inhibits thrombin. Once bound to the active site, thrombin cannot activate fibrinogen into fibrin, t...

Compare
Product Icatibant

is a synthetic peptidomimetic drug consisting of ten amino acids, and acts as an effective and specific antagonist of bradykinin B2 receptors. It has been approved in the EU for use in hereditary angioedema, and is under investigation for a number of other conditions in which bradykinin is thought to play ...

Compare
Product Liraglutide

Diabetes mellitus,
Liraglutide is a once-daily GLP-1 derivative for the treatment of type 2 diabetesLabel,2. The prolonged action of liraglutide is achieved by attaching a fatty acid molecule at position 26 of the GLP-1 molecule, enabling it to bind reversibly to albumin within the subcutaneou...

Compare
Product Octreotide

Octreotide is the acetate salt of a cyclic octapeptide. It is a long-acting octapeptide with pharmacologic properties mimicking those of the natural hormone somatostatin. Prevention and treatment of acute pancreatitis and upper gastrointestinal bleeding, and can also be used for portal hypertension a...

Compare